The effectiveness of 20 μg hepatitis B vaccine used for the prevention of HBV vertical transmission
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The effectiveness of 20 μg hepatitis B vaccine used for the prevention of HBV vertical transmission ; volume:12 ; number:1 ; day:11 ; month:7 ; year:2022 ; pages:1-8 ; date:12.2022
Scientific reports ; 12, Heft 1 (11.7.2022), 1-8, 12.2022
- Creator
-
Yonghao, Guo
Yanping, Chen
Qiaohua, Dou
Daxing, Feng
Yanyang, Zhang
Dongyang, Zhao
Wanshen, Guo
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-022-15744-z
- URN
-
urn:nbn:de:101:1-2022091409452498763151
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Yonghao, Guo
- Yanping, Chen
- Qiaohua, Dou
- Daxing, Feng
- Yanyang, Zhang
- Dongyang, Zhao
- Wanshen, Guo
- SpringerLink (Online service)
Other Objects (12)
The long-term immunogenicity of recombinant hepatitis B virus (HBV) vaccine: contribution of universal HBV vaccination in Italy
Novel anti-tick vaccine candidates based on HBV capsid-like particles
An autophagosome-based therapeutic vaccine for HBV infection: a preclinical evaluation
Telbivudine treatment started in early and middle pregnancy completely blocks HBV vertical transmission
Hepatitis B vaccine efficacy in HCV vertical infected infants
HBV X protein-based therapeutic vaccine accelerates viral antigen clearance by mobilizing monocyte infiltration into the liver in HBV carrier mice
Gewerkschaften: HBV
Fernmeldezentrale - HBV
Assessment of the HBV vaccine response in a group of HIV-infected children in Morocco
DGB-HBV, Stegmeier
Development of a therapeutic vaccine against chronic Hepatitis B virus infection in a preclinical model system : Therapeutic vaccine against chronic HBV infection
Obtaining HBV core protein VLPs carrying SARS-CoV-2 nucleocapsid conserved fragments as vaccine candidates
The long-term immunogenicity of recombinant hepatitis B virus (HBV) vaccine: contribution of universal HBV vaccination in Italy
Novel anti-tick vaccine candidates based on HBV capsid-like particles
An autophagosome-based therapeutic vaccine for HBV infection: a preclinical evaluation
Telbivudine treatment started in early and middle pregnancy completely blocks HBV vertical transmission
Hepatitis B vaccine efficacy in HCV vertical infected infants
HBV X protein-based therapeutic vaccine accelerates viral antigen clearance by mobilizing monocyte infiltration into the liver in HBV carrier mice
Gewerkschaften: HBV
Fernmeldezentrale - HBV
Assessment of the HBV vaccine response in a group of HIV-infected children in Morocco
DGB-HBV, Stegmeier
Development of a therapeutic vaccine against chronic Hepatitis B virus infection in a preclinical model system : Therapeutic vaccine against chronic HBV infection
Obtaining HBV core protein VLPs carrying SARS-CoV-2 nucleocapsid conserved fragments as vaccine candidates
The long-term immunogenicity of recombinant hepatitis B virus (HBV) vaccine: contribution of universal HBV vaccination in Italy
Novel anti-tick vaccine candidates based on HBV capsid-like particles
An autophagosome-based therapeutic vaccine for HBV infection: a preclinical evaluation
Telbivudine treatment started in early and middle pregnancy completely blocks HBV vertical transmission
Hepatitis B vaccine efficacy in HCV vertical infected infants
HBV X protein-based therapeutic vaccine accelerates viral antigen clearance by mobilizing monocyte infiltration into the liver in HBV carrier mice
Gewerkschaften: HBV
Fernmeldezentrale - HBV
Assessment of the HBV vaccine response in a group of HIV-infected children in Morocco
DGB-HBV, Stegmeier
Development of a therapeutic vaccine against chronic Hepatitis B virus infection in a preclinical model system : Therapeutic vaccine against chronic HBV infection